Inhibition of wild-type human immunodeficiency virus and reverse transcriptase inhibitor-resistant variants by Phyllanthus amarus

被引:73
作者
Notka, F
Meier, GR
Wagner, R
机构
[1] CMI Ctr Med Innovat AG, D-82152 Martinsried, Germany
[2] Univ Regensburg, Inst Med Mikrobiol & Hyg, D-93053 Regensburg, Germany
基金
英国医学研究理事会;
关键词
HIV; virus entry inhibitors; RT-resistant; Phyllanthus amarus; plant extract; tannin;
D O I
10.1016/S0166-3542(02)00213-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Substantial progress has been made in research on natural products which effectively inhibit HIV-1 replication. Many active compounds were isolated from traditionally used medicinal plants including Phyllanthus species. This study shows that aqueous as well as alcohol-based Phyllanthus amarus extracts potently inhibit HIV-1 replication in HeLa CD4(+) cells with 50% effective concentration (EC50) values ranging from 0.9 to 7.6 mug/ml. A gallotannin enriched fraction showed enhanced activity (0.4 mug/ml), and the purified gallotannins geraniin and corilagin were most active (0.24 mug/ml). HIV-1 replication was also blocked in CD4(+) lymphoid cells with comparable EC50 values. Applying a cell-based internalization assay, we could demonstrate 70-75% inhibition of virus uptake at concentrations of 2.5 mug/ml for the water/alcohol extract and geraniin. In addition, a concentration-dependent inhibition of HIV-1 reverse transcriptase (RT) could be demonstrated in vitro. The 50% inhibitory concentration (IC50) values varied from 1.8 to 14.6 mug/ml. The ability to inhibit replication of a variety of RT inhibitor-resistant HIV-1 strains points to the potential of P. amarus extracts, as natural products, in the chemotherapy of HIV infections. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:175 / 186
页数:12
相关论文
共 59 条
[21]  
206::AID-PTR409&gt
[22]  
3.0.CO
[23]  
2-D
[24]   Recent studies on natural products as anti-HIV agents [J].
Jung, M ;
Lee, S ;
Kim, H ;
Kim, H .
CURRENT MEDICINAL CHEMISTRY, 2000, 7 (06) :649-661
[25]   INHIBITORY EFFECT OF TANNINS ON REVERSE-TRANSCRIPTASE FROM RNA TUMOR-VIRUS [J].
KAKIUCHI, N ;
HATTORI, M ;
NAMBA, T ;
NISHIZAWA, M ;
YAMAGISHI, T ;
OKUDA, T .
JOURNAL OF NATURAL PRODUCTS, 1985, 48 (04) :614-621
[26]   ANTI-AIDS AGENTS .8. HIV AND REVERSE-TRANSCRIPTASE INHIBITION BY TANNINS [J].
KILKUSKIE, RE ;
KASHIWADA, Y ;
NONAKA, G ;
NISHIOKA, I ;
BODNER, AJ ;
CHENG, YC ;
LEE, KH .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (12) :1529-1534
[27]   DETECTION OF REPLICATION-COMPETENT AND PSEUDOTYPED HUMAN-IMMUNODEFICIENCY-VIRUS WITH A SENSITIVE CELL-LINE ON THE BASIS OF ACTIVATION OF AN INTEGRATED BETA-GALACTOSIDASE GENE [J].
KIMPTON, J ;
EMERMAN, M .
JOURNAL OF VIROLOGY, 1992, 66 (04) :2232-2239
[28]   MUTATIONAL ANALYSIS OF RESIDUE-190 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE [J].
KLEIM, JP ;
BENDER, R ;
KIRSCH, R ;
MEICHSNER, C ;
PAESSENS, A ;
RIESS, G .
VIROLOGY, 1994, 200 (02) :696-701
[29]   HIV WITH REDUCED SENSITIVITY TO ZIDOVUDINE (AZT) ISOLATED DURING PROLONGED THERAPY [J].
LARDER, BA ;
DARBY, G ;
RICHMAN, DD .
SCIENCE, 1989, 243 (4899) :1731-1734
[30]   CONVERGENT COMBINATION THERAPY CAN SELECT VIABLE MULTIDRUG-RESISTANT HIV-1 IN-VITRO [J].
LARDER, BA ;
KELLAM, P ;
KEMP, SD .
NATURE, 1993, 365 (6445) :451-453